Taiho Pharmaceutical's news releases are intended to provide information to the media. It may contain information about ethical drugs or products under development, however information contained in the news releases are not intended to constitute promotion, advertisement, or medical advice.
Site search
2011
December 12, 2011
Taiho Pharmaceutical Announces Personnel Changes （PDF：214.8 KB）
September 12, 2011
Taiho Pharmaceutical to Launch a New Anti-tumor Agent,
July 22, 2011
Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102
July 21, 2011
Taiho Pharmaceutical Co., Ltd and Nordic Group BV Enter into a Development and Commercialization Agreement for the recently EMA approved Anti-Cancer Drug Teysuno™ covering the EU and other Selected European Countries
June 09, 2011
MSD K.K. and Taiho Pharmaceutical Co., Ltd. Enter into Distribution Agreement for the Anticancer Compound Vorinostat in Japan（PDF：73.8 KB）
June 08, 2011
Presentation of results of GEST clinical study of TS-1 in patients with advanced pancreatic cancer to the American Society of Clinical Oncology
June 06, 2011
Presentation to the American Society of Clinical Oncology of results of final analysis of a clinical study in patients with unresectable colorectal cancer (FIRIS study)
April 13, 2011
Announcement of License Agreement on a New Antiemetic Combination Agent
March 25, 2011
Announcement of Promotion of Managing Director（PDF：42.5 KB）
March 15, 2011
Teysuno™ (S-1) Receives European Marketing Authorization As Therapy For Advanced Gastric Cancer
January 26, 2011
Taiho Pharmaceutical Announces Results of Gemcitabine and TS-1 Trial (GEST)on Advanced Pancreatic Cancer
News Releases
Select year from the Back Number
Back Number
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
